; and (ii) subparagraphs (A) through (G) of this paragraph shall not apply to research with marijuana or that compound, as applicable. . (b) Conforming amendment Section 102(16) of the Controlled Substances Act ( 21 U.S.C. 802(16) ) is amended by inserting or marijuana after The term marihuana . 3. Manufacturing of marijuana for clinical use Section 303 of the Controlled Substances Act ( 21 U.S.C. 823 ) is amended by adding at the end the following: (k) Registration of persons To manufacture and distribute marijuana (1) Manufacture and distribution for use in research The Attorney General shall register an applicant to manufacture or distribute marijuana on behalf of the Federal Government to the extent that the marijuana is intended to be used exclusively for legitimate research and scientific uses, in accordance with the applicable requirements under subsection (a) or (b) for registration of manufacturers or distributors of controlled substances in schedule I or II. (2) Manufacture and distribution for commercial production of FDA-approved drugs The Attorney General shall register an applicant to manufacture or distribute marijuana on behalf of the Federal Government exclusively for the purpose of commercial production of a drug containing or derived from marijuana that is approved by the Secretary under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ), in accordance with the applicable requirements under subsection (a) or (b) of this section for registration of manufacturers or distributors of controlled substances in schedule I or II. (3) No limit on number of manufacturers and distributors The Attorney General shall not impose a limit on the number of applicants eligible to be registered under paragraph (1) or (2). (4) Timing Not later than 30 days after the date on which the Attorney General receives an application for registration under paragraph (1) or (2), the Attorney General shall— (A) grant the application